Amgen Inc. (AMGN), headquartered in Thousand Oaks, California, discovers, develops, manufactures, and delivers human ...

Biotech company Amgen (NASDAQ:AMGN) will be announcing earnings results this Thursday afternoon. Here’s what investors should ...

Amgen stock toppled Friday as investors digested its "generally in-line" first-quarter report and expansion in the obesity treatment space.

Amgen Inc. (NASDAQ:AMGN) is one of Jim Cramer’s Hottest GLP-1 and Weight Loss Stock Picks. Amgen Inc. (NASDAQ:AMGN) is one of the largest drug companies in the world. The firm is currently developing ...

For the quarter ended March 2026, Amgen (AMGN) reported revenue of $8.62 billion, up 5.8% over the same period last year. EPS came in at $5.15, compared to $4.90 in the year-ago quarter. The reported ...

Looking ahead to 2030, our model projects AMGN could trade at an average price of $537.89, with a potential range between $403.41 and $672.36. This represents a potential 57.0% return from today's ...

TheFly reported on April 9 that Guggenheim increased its price target on AMGN from $347 to $351 while maintaining a Neutral ...

Amgen AMGN will report first-quarter 2026 results on April 30 after market close. In the last reported quarter, the company's ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.